What they were paid
Lineage Cell Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $57,500 | $0 | $45,990 | $0 | $103,490 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Lineage Cell Therapeutics, Inc. DEF 14A filed April 29, 2026, accession 0001193125-26-191556, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themNominating/Governance
The rest of the Lineage Cell Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Angus C. Russell | Independent Director | $120,990 |
| Brian M. Culley | Director | $0 |
| Deborah Andrews | Independent Director | $123,490 |
| Dipti Amin | Independent Director | $103,490 |
| Michael H. Mulroy | Independent Director | $160,990 |
| Neal C. Bradsher | Independent Director | $118,490 |
The full Lineage Cell Therapeutics compensation record
free company briefThis page is one director within Lineage Cell Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat